Domov › Rakovina pľúc › Virginia › Arlington
Klinické štúdie Rakovina pľúc v meste Arlington, VA
41 štúdií pre Rakovina pľúc hľadá účastníkov v zariadeniach v meste Arlington a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Prebieha náborFáza 3
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 míľ odtiaľ
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Prebieha náborFáza 1/2
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
Prebieha náborFáza 2
- Virginia Cancer Specialists (VCS) ( Site 0408), Fairfax · 11 míľ odtiaľ
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Prebieha náborFáza 3
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Prebieha náborFáza 3
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
A Study of PHN-012 in Patients With Advanced Solid Tumors
Prebieha náborFáza 1
- PHN-012-001 Site, Fairfax · 11 míľ odtiaľ
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
Prebieha náborFáza 1
- Inova Schar Cancer Infusion Pharmacy, Fairfax · 11 míľ odtiaľ
- Inova Schar Cancer, Fairfax · 11 míľ odtiaľ
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Prebieha náborFáza 2
- Research Site, Fairfax · 11 míľ odtiaľ
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Prebieha náborFáza 2/3
- Virginia Cancer Specialists - Arlington, Arlington
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Prebieha náborFáza 1/2
- NEXT Oncology Virginia, Fairfax · 11 míľ odtiaľ
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Prebieha náborFáza 1/2
- Next Oncology Virginia Cancer Specialist, Fairfax · 11 míľ odtiaľ
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Prebieha náborFáza 1
- NEXT - Virginia, Fairfax · 11 míľ odtiaľ
BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
Prebieha náborFáza 3
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Prebieha náborFáza 1/2
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Prebieha náborFáza 1
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Prebieha náborFáza 3
- USO - Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1
- USO-Virginia Cancer Specialists, PC, Fairfax · 11 míľ odtiaľ
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Prebieha náborFáza 1/2
- Avenzo Therapeutics Recruiting Site, Fairfax · 11 míľ odtiaľ
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Prebieha náborFáza 1
- NEXT Oncology, Fairfax · 11 míľ odtiaľ
The Vanguard Study: Testing a New Way to Screen for Cancer
Prebieha náborVítaní zdravých dobrovoľníkov
- Inova Schar Cancer Institute, Fairfax · 11 míľ odtiaľ
- Inova Fair Oaks Hospital, Fairfax · 11 míľ odtiaľ
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
Prebieha náborFáza 3
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Prebieha náborFáza 3
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Prebieha náborFáza 3
- Inova Schar Cancer Institute, Fairfax · 11 míľ odtiaľ
- Inova Fair Oaks Hospital, Fairfax · 11 míľ odtiaľ
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Prebieha náborFáza 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
Prebieha náborFáza 1/2
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
Prebieha náborFáza 1
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Prebieha náborFáza 1/2
- NEXT Oncology Virginia, Fairfax · 11 míľ odtiaľ
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Prebieha náborFáza 1
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Prebieha náborFáza 1
- Research Site, Fairfax · 11 míľ odtiaľ
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Prebieha náborFáza 2
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 míľ odtiaľ
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Prebieha náborFáza 1
- NEXT Oncology Virginia, Fairfax · 11 míľ odtiaľ
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Prebieha náborFáza 1/2
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Prebieha náborFáza 1/2
- Next Oncology Virginia, Fairfax · 11 míľ odtiaľ
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
Prebieha náborFáza 1/2
- NEXT Oncology, Fairfax · 11 míľ odtiaľ
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Prebieha náborFáza 2
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 míľ odtiaľ
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Prebieha náborFáza 2/3
- Kaiser Permanente Tysons Corner Medical Center, McLean · 5 míľ odtiaľ
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma
Prebieha náborFáza 2
- Inova Fairfax Hospital, Fairfax · 11 míľ odtiaľ
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Prebieha náborFáza 1/2
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Prebieha náborFáza 1/2
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1
- NEXT Virginia, Fairfax · 11 míľ odtiaľ
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Prebieha náborFáza 1/2
- Virginia Cancer Specialists, Fairfax · 11 míľ odtiaľ
Štúdie Rakovina pľúc v iných mestách
- Houston, TX78 štúdií
- Boston, MA62 štúdií
- New York City, NY60 štúdií
- Los Angeles, CA45 štúdií
- Washington, DC41 štúdií
- Chicago, IL41 štúdií
- Nashville, TN40 štúdií
- Baltimore, MD40 štúdií
- St. Louis, MO39 štúdií
- Columbus, OH37 štúdií
- Philadelphia, PA36 štúdií
- Seattle, WA33 štúdií
Iné štúdie v Arlington
- Nemalobunkový karcinóm pľúc104 štúdií
- Metastatická rakovina53 štúdií
- Kolorektálny karcinóm52 štúdií
- Rakovina (všetky typy)48 štúdií
- Rakovina prsníka46 štúdií
- Rakovina vaječníkov46 štúdií
- Rakovina endometria39 štúdií
- Rakovina pankreasu33 štúdií
- Skvamóznocelulárny karcinóm hlavy a krku26 štúdií
- Malobuněčný rakovina plic23 štúdií
- Trojnásobne negatívny karcinóm prsníka20 štúdií
- Rakovina žalúdka20 štúdií
Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.